Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:OCUL 6 December 2025 - 9 December 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

Ocular Therapeutix shares surged 28.1% to $16.11 on December 8, hitting a new 52-week high after the company announced plans to file an accelerated NDA for its retina drug AXPAXLI in wet AMD, based on a single Phase 3 trial. Trading volume spiked, and year-to-date gains reached about 44%. The company aims to submit the NDA after year-one SOL-1 trial data in Q1 2026.
9 December 2025

Stock Market Today

  • Planet Labs Q4 2025 Earnings Beat as Shares Climb on Strong Sales and Backlog Growth
    March 20, 2026, 10:18 AM EDT. Planet Labs (NYSE: PL) surpassed revenue estimates in Q4 CY2025, reporting $86.82 million, a 41.1% year-on-year increase and 10.6% above analyst projections. The company's adjusted earnings per share of zero outperformed forecasts. Guidance for Q1 CY2026 anticipates $89 million in revenue, exceeding estimates by 5.6%. Despite a 41.5% operating loss margin, the satellite imaging firm's backlog surged 80.6% year-over-year to $900.4 million, signaling robust demand for its Earth observation services. However, EBITDA guidance for 2027 fell short of expectations. Planet Labs, operating the world's largest fleet of small Earth observation satellites, continues to deliver strong top-line growth, with five-year annualized revenue growth at 22.2%, highlighting sustained market interest amid expansion opportunities.
Go toTop